Nuravax
PrivateLast Round
Grant
May 5, 2025
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nuravax is a biotechnology company that engineers precision immunotherapies to prevent and cure Alzheimer's and Parkinson's diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuravax Comparables
Compare Nuravax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vaxxinity, Inc. | 79% | |
| Axon Neuroscience | 78% | |
| Grifols | 77% |
Nuravax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 5, 2025 |
Nuravax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 537% MoM, reaching 1.7K.
- Apr 16, 2026
Monthly visitors grew 150% MoM, reaching 1.6K.
Nuravax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nuravax's valuation, stock price, and market status.
Is Nuravax a public or private company?
Nuravax is a private company.
What is the current stock price of Nuravax?
Nuravax is a private company with no public stock price. No recent secondary market data is available.
How much is Nuravax worth (valuation)?
Valuation information for Nuravax is not publicly available.
Can I buy Nuravax stock?
Nuravax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nuravax's last funding round?
Funding round information for Nuravax is not publicly available.
Who are the main investors in Nuravax?
Investor information for Nuravax is not publicly disclosed.
Will Nuravax IPO soon?
No public IPO plans have been announced for Nuravax.
How can I track Nuravax secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nuravax's secondary market activity and sign up for updates.